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The importance of early referral for multidisciplinary management
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Summary
Pulmonary artery sarcomas are uncommon intracardiac tumours with 
poor prognosis. We report the case of a 69-year-old woman in good health 
presenting with rapidly progressive dyspnoea and an unfamiliar systolic 
murmur. Echocardiography revealed pulmonary valve stenosis due to an 
obstructing mobile mass. Imaging studies confirmed the presence of a 
contrast-enhancing lesion adherent to the valve, extending into the pulmo-
nary trunk and right ventricular outflow tract, and suggestive of malig-
nancy. Endovascular biopsy was attempted with no success. Surgical re-
section with autologous graft valve replacement and pulmonary artery 
reconstruction was performed. Postoperative histological examination 
confirmed the diagnosis of an undifferentiated pleomorphic sarcoma. Pul-
monary artery sarcoma should be considered as a rare differential diagno-
sis in patients presenting with dyspnoea and a crescendo–decrescendo 
systolic murmur increasing with inspiration. Echocardiography is a useful 
first diagnostic approach but multi-imaging assessment is almost always 
necessary for definite diagnosis. Our case provides insights into the chal-
lenges met by cardiologists, radiologists and cardiac surgeons in the man-
agement of such cases.
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Case description
A 69-year-old Caucasian woman presented to her 
general practitioner with new onset fatigue and rap-
idly progressive dyspnoea on exertion. Upon physi-
cal examination the patient was afebrile, blood pres-
sure was 116/72 mm Hg, pulse rate 76/min and 
respiration rate 12/min. Heart sounds were normal, 
but a new, 3/6, crescendo–decrescendo systolic mur-
mur, which increased during deep inspiration and 
was maximal along the left sternal border, was noted. 
Laboratory studies of electrolytes, renal function, 
liver and cardiac enzymes, acute phase reactants and 
complete blood count were within normal limits, as 
were a 12-lead ECG and a chest radiograph. 
Transthoracic echocardiography (TTE) revealed a 
mod erate pulmonary valve stenosis caused by a glob-
ular mass protruding into the right ventricular out-
flow tract (RVOT) during diastole (fig. 1). The maxi-
mum pulmonary pressure gradient was measured at 
42 mm Hg (mean 30 mm Hg). Left as well as right ven-
tricle size and function were normal.
The patient was promptly referred to our institution 
where cardiac computed tomography (CT) revealed 
a 25 × 35 × 24 mm mass attached to the RVOT and 
extending into the pulmonary trunk through the 
pulmonary valve (fig. 2). After intravenous injection 
of 60–80 ml iodinated contrast material, late image 
acquisition showed inhomogeneous enhancement of 
the mass and mural enhancement of the pulmonary 
trunk suggestive of infiltration. This technique in the 
context of cardiac CT consists of acquiring images 
60 seconds after CT angiography in order to optimise 
tissue enhancement. Fludeoxyglucose (18F) positron 
emission tomography-CT (18F-FDG PET-CT) revealed 
mild metabolic activity of the mass, with no signs of 
metastasis (fig. 3). Finally, cardiac magnetic reso-
nance imaging (MRI) confirmed proximal extension 
of the valve mass, 4 cm towards the pulmonary 
trunk, without apparent invasion of the bifurcation 
(fig. 4). A hyperintense signal in T2-weighted images 
indicated oedema, whereas moderate signal-en-
hance ment during resting perfusion suggested rich 
vascularisation. Intense signals on gadolinium en-
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Figure 1: (A) TTE parasternal long axis view of the pulmonary artery. The tumour is recognised as a large round mass invading the pulmonary valve. 
(B) Transoesophageal echocardiography (TOE) in transgastric inflow–outflow view of the right ventricle. The tricuspid valve and the right ventricular apex 
are seen at the top of the picture. The pulmonary valve is replaced by a ball-like tumour (*) obstructing the RVOT. 
Ao = aorta; PA = pulmonary artery; RV = right ventricle; RVOT = right ventricle outflow tract; TV = tricuspid valve.
Figure 2: Cardiac computed tomography, 2d multi-planar reformation showing the voluminous mass (*) attached 
to the pulmonary valve (A) and protruding in the pulmonary trunk during systole (B).
Ao = aorta; LV = left ventricle; PA = pulmonary artery; RVOT = right ventricle outflow tract.
hancement sequences suggested rich extracellular 
content (fibrosis or extracellular matrix), but no sig-
nificant necrosis (fig. 5). 
A provisory diagnosis of intracardiac malignancy 
was made on clinical (rapid installation of symp-
toms) and imaging (vascular infiltrative mass) 
grounds, and endovascular biopsy was attempted. 
The procedure was uneventful, but yielded limited 
material for histology. The case was discussed by a 
multidisciplinary panel involving cardiologists, ra-
diologists and a cardiothoracic surgeon, and surgery 
was decided on. The time delay from first diagnosis 
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on TTE to the operation was 22 days. During the pro-
cedure, a bulky, white mass, densely adherent and in-
filtrating the pulmonary valve and all of the pulmo-
nary infundibulum was identified and removed, 
along with the deformed pulmonary valve, part of 
the RVOT, as well as most of the pulmonary trunk as 
proximally as possible to the bifurcation. An autolo-
gous graft was used to replace the valve; the right 
ventricle was then anastomosed to the distal part of 
the pulmonary artery. Postoperative histology re-
vealed a mesenchymal tumour consisting of highly 
atypical spindle cells without specific differentiation 
(fig. 6) [1]. Given the retrograde extension of the mass 
and the possibility of residual fragments very low in-
side the RVOT, the patient was referred for adjuvant 
chemotherapy and radiotherapy after six weeks of 
convalescence in a cardiac rehabilitation centre. 
Discussion 
Our case highlights the major impediments encoun-
tered during management of these rare and often 
Figure 4: (A) Cardiac magnetic resonance imaging (MRI) steady-state free precession (SSFP) cine acquisition in inflow–outflow 
view of the right ventricle. The tumour is seen as a massive thickening of the pulmonary valve (*). Note also the thickening  
of the anterior wall of the pulmonary trunk (arrows). (B) Corresponding acquisition with a phase-sensitive inversion-recovery 
sequence after contrast injection. There is homogenous late gadolinium enhancement of the tumour (*) and of the anterior  
wall of the pulmonary trunk (arrows).
Ao = aorta; PA = pulmonary artery; RPA = right pulmonary artery; RA = right atrium; RV = right ventricle.
Figure 3: Fludeoxyglucose (18F) positron emission tomography-computed tomography (18F-FDG PET-CT) showing discrete metabolic activity 
of the mass (arrow), with no evidence of other lesion.
Ao = aorta; PA = pulmonary artery; RV = right ventricle.
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fatal intracardiac tumours; from timely and accurate 
diagnosis to surgical resection and adjuvant care, 
pulmonary artery sarcomas (PAS) represent a diag-
nostic and therapeutic challenge for cardiologists, 
radiologists, cardiac surgeons and oncologists.
Typical onset age is 45–55 years with a female to male 
ratio of 2:1. The tumour typically arises within the 
pulmonary trunk and spreads into the pulmonary 
arteries. Embryologically, it originates from the bul-
bus cordis, a structure that later gives birth to both 
the RVOT and pulmonary trunk, which could, in our 
case, explain valve involvement and RVOT extension. 
As with the majority of intracardiac tumours, pre-
sentation is non-specific, with dyspnoea on exertion, 
chest or back pain, cough and haemoptysis being 
common symptoms. In many cases, the clinical pre-
sentation mimics chronic thromboembolic pulmo-
nary hypertension, and in advanced stages constitu-
tional symptoms appear. Physical examination 
remains unremarkable until late. Our case is unique 
in the sense that it presented as a new unfamiliar 
murmur that alarmed the primary physician. Such 
a finding is extremely rare and highlights the para-
mount importance of good auscultation skills and 
a clinical acumen. A new harsh systolic murmur that 
increases with inspiration indicates pulmonary ste-
nosis and warrants further investigation with echo-
cardiography. TTE may show an increased gradient 
across a narrowed RVOT [2]. The presence of a pedun-
culated lesion arising from the RVOT, or pulmonary 
valve or trunk should always raise suspicion of PAS 
[3] and prompt a thoracic CT or a cardiac MRI.
Figure 5: (A) T1-weighted image; the mass (arrow) has a signal iso-intense to the myocardium. (B) T2-weighted image; the mass 
has a signal hyper-intense to the myocardium indicating presence of tissue oedema. (C) Late gadolinium enhancement 
sequen ce; the mass shows bright enhancement indicating rich vascularisation. (D to F) Perfusion imaging; (D) contrast in the 
right cardiac chambers; (E) contrast in the left cardiac chambers; (F) contrast enhancing the myocardium: the mass shows  
moderate first-pass enhancement with peak signal intensity lower than that of the myocardium. 
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CT findings can be misleading in over 50% of cases, as 
PAS is confused with the far more common condition 
of central pulmonary embolism. Both entities pre-
sent with a filling defect in the pulmonary arteries. 
Suggestive of PAS are an inhomogeneous, soft tissue 
density, with the filling defect occupying the entire 
lumen of the pulmonary trunk, along with delayed 
contrast enhancement on angiography [4]. Once sus-
picion is raised, PET-CT and MRI are helpful to differ-
entiate fully the mass. Preoperative histological 
diagnosis is generally not possible although it should 
be attempted through CT-guided transthoracic aspi-
ration, transvenous catheter biopsy or transbron-
chial biopsy. In most cases definitive diagnosis is 
made only during surgery or at autopsy. Surgery 
 remains the cornerstone of management, offering 
definite diagnosis, clinical improvement and the best 
prognosis [5]. Even if curative resection is not possi-
ble, palliative resection can provide symptom relief 
by restoring haemodynamics. Reported interven-
tions range from bilateral pneumonectomy, pulmo-
nary endarterectomy (PEA) with or without pneumo-
nectomy and with or without reconstruction of the 
pulmonary artery to debulking and palliative stent-
ing. Regarding adjuvant therapy, combined chemo- 
and radiotherapy should be adopted in nearly every 
case to extend palliation. Overall, PAS represents a 
fat al disease, with a mean survival time with out surgi-
cal intervention of 1.5 months. Survival of 36.5 ± 20.2 
months has been reported for patients benefiting 
from a “curative” resection while 11 ± 3 months for 
those undergoing “incomplete” resection [5]. 
In conclusion, it is important that physicians recog-
nise the clinical features associated with PAS and in-
clude it as a differential diagnosis in the appropriate 
setting. Early referral for multidisciplinary manage-
ment in a tertiary centre offers the only chance for 
prolonged survival and improved quality of life.
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Figure 6: (A) (Haematoxylin and eosin; × 40) Postoperative 
histology revealed a poorly differentiated tumour composed  
of a proliferation of spindle cells with fibroblastic differentia-
tion (black arrows). Some areas have a fibromyxoid pattern 
(*). (B) (haematoxylin and eosin; × 200); Highly atypical giant 
spindle cell (white arrows). (C) Macroscopic aspect of the 
mass.
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